Products, Services, Technologies

Erasmus University Medical Centre (Erasmus MC)

Erasmus MC is one of Europe\'s largest academic medical centers, based in Rotterdam. It conducts world-leading research across medicine, public health, and infectious disease, including significant AMR research programs covering resistance surveillance, novel diagnostics, therapeutic development, and infection prevention. As a teaching hospital and research institution, Erasmus MC trains the next generation of clinicians and scientists addressing drug resistance globally.

eSHIFT Partner Network

eSHIFT Partner Network is a Maastricht-based Swiss not-for-profit specializing in scaling digital health information systems globally. It works in low- and middle-income country settings to implement and expand digital health infrastructure , including systems that support AMR surveillance, clinical data collection, and antibiotic prescribing monitoring , building the foundational health IT capacity that stewardship and resistance tracking programs depend on.

EU-OPENSCREEN ERIC

EU-OPENSCREEN ERIC is a pan-European research infrastructure providing shared access to high-throughput chemical screening platforms and a compound collection of up to 300,000 molecules for academic and industrial researchers. It supports early-stage drug discovery across therapeutic areas including AMR, enabling scientists to identify new hit compounds targeting drug-resistant bacteria through systematic chemical biology screening.

Evotec

Evotec\'s infectious disease division, operating from Lyon, France , built on the former Sanofi anti-infectives unit acquired in 2018 , focuses specifically on AMR, tuberculosis, and malaria. It combines Evotec\'s drug discovery platforms with deep anti-infective expertise to develop novel antibacterial candidates through public-private partnerships, including collaborations with GARDP, CARB-X, and government funders advancing therapeutics for WHO priority pathogens.

Evotec

Evotec is a Hamburg-based global drug discovery and development platform company with over 4,000 scientists across 14 sites. Its infectious disease unit , acquired from Sanofi in 2018 , focuses on AMR, tuberculosis, and malaria, combining Evotec\'s multimodality platforms with anti-infective expertise to develop novel therapeutics through public-private partnerships with governments, foundations, and pharmaceutical companies.

FFUND

At FFUND we combine the expertise from seasoned Life Sciences and AMR business experts, on-top-of-the field innovation specialists and technology to provide a consultancy service that boosts your innovative performance and long-term business success.

Firefinch Software

Firefinch Software is an Oxford-based health technology company developing digital tools for clinical decision support and antimicrobial stewardship in hospital settings. Its software platforms support clinical microbiologists and infectious disease physicians in interpreting resistance data, implementing stewardship protocols, and optimizing antibiotic prescribing decisions , improving the quality and consistency of AMR management in complex clinical environments.

FluoretiQ Limited

FluoretiQ is a Bristol-based diagnostics company developing rapid, point-of-care tests to identify the right antibiotic for the right patient at the time of first prescription. Its technology aims to eliminate the guesswork that drives inappropriate antibiotic prescribing , making it a direct stewardship tool for reducing AMR by ensuring patients receive targeted treatment from day one of infection.

Fraunhofer IZI-BB

Fraunhofer IZI-BB is the Bioanalytics and Bioprocesses branch of Germany\'s Fraunhofer Institute for Cell Therapy and Immunology, based in Potsdam. It conducts applied research in food and environmental analysis, diagnostics, drug development, and process engineering , including AMR-relevant work on rapid diagnostic tools, antimicrobial bioassays, and innovative bioprocess technologies to support the development of new anti-infective agents.

Global Access Diagnostics

Global Access Diagnostics is a Thurleigh, UK–based company developing affordable, field-deployable rapid diagnostic tests for infectious diseases in low-resource settings. Its AMR-relevant portfolio includes rapid tests designed for high-burden regions where laboratory infrastructure is limited , providing clinicians with actionable diagnostic information to guide appropriate antibiotic prescribing in the settings where diagnostic-guided stewardship is most needed and least available.

Iceni Glycoscience

Iceni Glycoscience is a Norwich-based biotechnology company developing carbohydrate-based therapeutics and diagnostics for infectious diseases. Its research focuses on glycan-targeting approaches to combat bacterial pathogens , exploiting the role of bacterial surface sugars in virulence and resistance , to develop novel anti-infectives that function through mechanisms distinct from existing antibiotic classes and less susceptible to known resistance pathways.

iFAST Diagnostics Limited

iFAST Diagnostics is a Belfast-based company developing rapid, affordable diagnostic tools for infectious disease and antimicrobial resistance detection in resource-limited settings. Its point-of-care platform targets healthcare systems in low- and middle-income countries , where diagnostic capacity is most limited and AMR burden is highest , providing fast pathogen identification and resistance profiling to support targeted antibiotic prescribing and stewardship programs.

IHMA Europe

IHMA , International Health Management Associates , is a global contract research and microbiology services organization with offices in Monmouth, UK and Schaumburg, Illinois. It specializes in antimicrobial surveillance, susceptibility testing, clinical microbiology, and regulatory support for antimicrobial drug development, providing the laboratory and analytical services that pharma companies need to advance new antibiotic candidates through clinical trials.

IHMA Inc

Imspex Medical

Imspex Medical is a Welsh medical diagnostics company developing breath-based diagnostic technology for the rapid identification of bacterial infections and sepsis. Its GeNose platform analyzes volatile organic compounds in exhaled breath to detect infection markers, potentially enabling clinicians to identify drug-resistant infections faster than conventional culture methods, supporting earlier and more targeted antibiotic treatment decisions.

Ingenious Probiotics

Sustainable products enriched with probiotic bacteria that restore a healthy microflora balance

Institute for Life Science Entrepreneurship

Entrepreneurship (ILSE) (ilsebio.com)ILSE is New Jersey\'s leading life science innovation center, accelerating discoveries that improve human and global health. It supports early-stage biotech and life science companies through incubator facilities, mentorship, funding connections, and entrepreneurship programs , providing the infrastructure and expertise needed to translate scientific discoveries, including in infectious disease and AMR, from laboratory research to viable commercial products.

KU Leuven

The MICA Lab at KU Leuven is a Belgian academic research group investigating the molecular and cellular mechanisms of antimicrobial resistance and bacterial persistence. Its research focuses on understanding how bacteria tolerate and resist antibiotic treatment , including stress responses, biofilm formation, and persister cell biology , generating fundamental scientific knowledge that informs the development of new strategies to overcome treatment failure.

Labcrest Laboratories Limited

Labcrest Medical Diagnostics and Clinic is an Abuja, Nigeria–based diagnostic laboratory providing fast and reliable medical testing services to the local community. Operating in a high-AMR-burden region with limited diagnostic infrastructure, Labcrest contributes to improving clinical care through accessible pathology services , including microbiology and antimicrobial susceptibility testing , supporting appropriate antibiotic use in Nigeria.

Labmaster Ltd

Labmaster is a Turku, Finland–based laboratory services company providing specialist microbiology and diagnostics services, including antimicrobial susceptibility testing and resistance profiling. It supports pharmaceutical companies, hospitals, and research institutions with expert laboratory analysis and contract research services , including preclinical and clinical microbiology testing , for antimicrobial drug development and infectious disease research programs.